Indoco Remedies Financial Statements

Indoco Remedies (INDOCO) reported revenue of ₹16.65B in FY2025 with net income of -₹779.51M. Total assets stood at ₹24.30B and free cash flow was -₹2.61B.

Indoco Remedies Income Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Revenue		12.42B	15.43B	16.71B	18.27B	16.65B
Cost of Rev. Cost of Revenue		-3.54B	-4.57B	-5.21B	-5.59B	-4.98B
Gross Profit		8.87B	10.86B	11.50B	12.68B	11.67B
SGA Sales, General & Admin		-6.63B	-7.57B	-8.61B	-10.14B	-4.70B
Op. Income Operating Income		1.51B	2.51B	2.18B	1.62B	-145.87M
PBT Profit Before Tax		1.32B	2.37B	1.93B	1.36B	-743.71M
Net Income		930.50M	1.55B	1.42B	970.10M	-779.51M
Dil. Shares Diluted Shares		92.15M	92.15M	92.26M	92.26M	92.29M
Diluted EPS		10.10	16.80	15.42	10.51	-8.45

Figures in ₹ — millions (M), billions (B), trillions (T). EPS is earnings per share.

Understanding the Income Statement

The income statement shows Indoco Remedies's revenue and expenses over a period. Revenue minus costs gives gross profit; after operating expenses, interest, and taxes, the remainder is net income. Diluted EPS divides net income by all shares that could exist if options and convertibles were exercised.

Indoco Remedies Balance Sheet

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Curr. assets Total current assets		6.23B	7.74B	8.14B	9.55B	10.01B
Non-curr. assets Total non-current assets		6.93B	7.12B	8.45B	11.90B	14.29B
Total assets		13.15B	14.86B	16.58B	21.45B	24.30B
Curr. liabilities Total current liabilities		4.07B	4.25B	4.25B	6.12B	8.08B
Non-curr. liab. Total non-current liabilities		1.39B	1.57B	2.05B	4.22B	6.04B
Total liabilities		5.46B	5.81B	6.30B	10.34B	14.12B
Total equity		7.69B	9.05B	10.28B	11.10B	10.18B
Total liab. & eq. Total liabilities & equity		13.15B	14.86B	16.58B	21.45B	24.30B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding the Balance Sheet

The balance sheet captures Indoco Remedies's financial position at a point in time — what it owns (assets), what it owes (liabilities), and the residual value to shareholders (equity). Total assets always equals total liabilities plus equity.

Indoco Remedies Cash Flow Statement

Hover the chart icon for year-over-year change.

FY 2021 – FY 2025

Item	Chart	2021	2022	2023	2024	2025
Net Income		1.32B	2.37B	1.93B	1.24B	-753.65M
Operating CF Cash flow Operating Activities		822.20M	1.74B	1.79B	1.55B	949.27M
Capex Investments in PPE		-768.50M	-1.25B	-2.07B	-4.26B	-3.56B
Investing CF Cash flow Investing Activities		-666.90M	-1.21B	-2.08B	-4.33B	-3.39B
Dividend Paid		-27.90M	-137.93M	-207.21M	-207.06M	-139.02M
Financing CF Cash flow Financing Activities		-298.70M	-443.72M	228.04M	2.80B	2.41B
Cash (start) Cash at beginning of period		237.60M	94.18M	174.65M	109.25M	148.56M
Cash (end) Cash at end of period		94.20M	174.65M	109.25M	148.56M	120.96M
FCF Free Cash Flow		53.70M	485.04M	-284.23M	-2.71B	-2.61B

Figures in ₹ — millions (M), billions (B), trillions (T).

Understanding Cash Flow

The cash flow statement tracks how Indoco Remedies's cash moves through operations, investing, and financing activities. Free cash flow — operating cash minus capital expenditure — shows what is available to return to shareholders.

Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025